- Home
- VIRC vs EPRX Comparison
VIRC vs EPRX Comparison
Compare VIRC & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- EPRX
- Stock Information
- Founded
- VIRC 1950
- EPRX 2011
- Country
- VIRC United States
- EPRX Canada
- Employees
- VIRC N/A
- EPRX N/A
- Industry
- VIRC Industrial Specialties
- EPRX
- Sector
- VIRC Consumer Discretionary
- EPRX
- Exchange
- VIRC Nasdaq
- EPRX NYSE
- Market Cap
- VIRC 158.2M
- EPRX 130.0M
- IPO Year
- VIRC N/A
- EPRX N/A
- Fundamental
- Price
- VIRC $9.46
- EPRX $3.28
- Analyst Decision
- VIRC Buy
- EPRX Strong Buy
- Analyst Count
- VIRC 1
- EPRX 1
- Target Price
- VIRC $19.00
- EPRX $9.00
- AVG Volume (30 Days)
- VIRC 66.9K
- EPRX 12.7K
- Earning Date
- VIRC 04-11-2025
- EPRX 03-20-2025
- Dividend Yield
- VIRC 1.06%
- EPRX N/A
- EPS Growth
- VIRC N/A
- EPRX N/A
- EPS
- VIRC 1.53
- EPRX N/A
- Revenue
- VIRC $280,375,000.00
- EPRX N/A
- Revenue This Year
- VIRC $6.43
- EPRX N/A
- Revenue Next Year
- VIRC $2.38
- EPRX N/A
- P/E Ratio
- VIRC $6.15
- EPRX N/A
- Revenue Growth
- VIRC 5.68
- EPRX N/A
- 52 Week Low
- VIRC $9.08
- EPRX $2.20
- 52 Week High
- VIRC $18.50
- EPRX $4.48
- Technical
- Relative Strength Index (RSI)
- VIRC 35.68
- EPRX N/A
- Support Level
- VIRC $9.43
- EPRX N/A
- Resistance Level
- VIRC $9.71
- EPRX N/A
- Average True Range (ATR)
- VIRC 0.32
- EPRX 0.00
- MACD
- VIRC -0.00
- EPRX 0.00
- Stochastic Oscillator
- VIRC 15.65
- EPRX 0.00
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.